Establishing new mouse models, to delete Tet genes at various developmental stages and at specific T cell subsets will shed light on the precise biological roles of TET2 and TET3 in immune response and blood cancer development. This evidence concerns the gene TET2 and hematopoietic and lymphoid system neoplasm.